The Canadian cannabis producer and distributor plans to issue up to $400 million in additional stock as it continues its expansion plans amid ongoing legalization of pot-infused products in North America and internationally.
In particular, Juul is breaking the law by selling and distributing its e-cigarettes 'as modified risk tobacco products without an FDA order in effect that permits such sale or distribution,' the FDA's letter states.
The CFTC releases weekly stats on market composition -- we should all pay attention.
The suit, filed in a San Francisco court, describes attacks over 18 months in several states and says, among other things, that the ride-hailing company didn't properly respond to the women's complaints or to police inquiries.
The FTC had been probing Alphabet's YouTube for possible violations of children's data privacy laws.
Several watchers and market players are deep in the weeds, tracking short action and key companies like Canopy Growth, trying to find out whether the industry has turned over a new leaf.
No company is safe from the litigation risk tied to the drug epidemic, but Johnson & Johnson may be one of the few guaranteed to survive.
Wall Street expects the healthcare giant can take the jolt from the penalty delivered by an Oklahoma judge in the state's opioid case against J&J.
With total deals trending toward hundreds of billions, investors may be eager to bet on who's next to be acquired.
An investigation of Amazon's marketplace found thousands of items that have been banned or declared unsafe by regulators, or had misleading labels. Third-party sellers comprise an increasing proportion of items sold on Amazon.